A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis

NCT02081183 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: Mycophenolate mofetil (MMF)
DRUG: Cyclophosphamide, Maintenance Phase
DRUG: Cyclophosphamide, Induction Phase
DRUG: Prednisone

Sponsor

Hoffmann-La Roche